ABOUT THE PRODUCT
The MammaPrint test is a 70-gene breast cancer recurrence assay that provides a risk of recurrence score. It is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines.
Information is owner-confirmed
Last updated 4 months ago
Price range
Other products/services from Agendia
BluePrint
Biotechnology
N/A
Agendia
United States (US)